Targeting mammalian target of rapamycin (mTOR) for health and diseases

Chi Kwan Tsang, Haiyan Qi, Leroy-Fong Liu, X. F Steven Zheng

Research output: Contribution to journalArticle

310 Citations (Scopus)

Abstract

The macrolide rapamycin is used clinically to treat graft rejection and restenosis. Mammalian target of rapamycin (mTOR) is a central controller of cellular and organism growth that integrates nutrient and hormonal signals, and regulates diverse cellular processes. New studies have linked mTOR to several human diseases including cancer, diabetes, obesity, cardiovascular diseases and neurological disorders. Recent data have also revealed that mTOR is involved in the regulation of lifespan and in age-related diseases. These findings demonstrate the importance of growth control in the pathology of major diseases and overall human health, and underscore the therapeutic potential of the mTOR pathway.

Original languageEnglish
Pages (from-to)112-124
Number of pages13
JournalDrug Discovery Today
Volume12
Issue number3-4
DOIs
Publication statusPublished - Feb 2007
Externally publishedYes

Fingerprint

Sirolimus
Health
Macrolides
Graft Rejection
Growth
Nervous System Diseases
Cardiovascular Diseases
Obesity
Pathology
Food
Neoplasms

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Targeting mammalian target of rapamycin (mTOR) for health and diseases. / Tsang, Chi Kwan; Qi, Haiyan; Liu, Leroy-Fong; Zheng, X. F Steven.

In: Drug Discovery Today, Vol. 12, No. 3-4, 02.2007, p. 112-124.

Research output: Contribution to journalArticle

Tsang, Chi Kwan ; Qi, Haiyan ; Liu, Leroy-Fong ; Zheng, X. F Steven. / Targeting mammalian target of rapamycin (mTOR) for health and diseases. In: Drug Discovery Today. 2007 ; Vol. 12, No. 3-4. pp. 112-124.
@article{5ed7a5fba2c14cb88b5d74a806f6973b,
title = "Targeting mammalian target of rapamycin (mTOR) for health and diseases",
abstract = "The macrolide rapamycin is used clinically to treat graft rejection and restenosis. Mammalian target of rapamycin (mTOR) is a central controller of cellular and organism growth that integrates nutrient and hormonal signals, and regulates diverse cellular processes. New studies have linked mTOR to several human diseases including cancer, diabetes, obesity, cardiovascular diseases and neurological disorders. Recent data have also revealed that mTOR is involved in the regulation of lifespan and in age-related diseases. These findings demonstrate the importance of growth control in the pathology of major diseases and overall human health, and underscore the therapeutic potential of the mTOR pathway.",
author = "Tsang, {Chi Kwan} and Haiyan Qi and Leroy-Fong Liu and Zheng, {X. F Steven}",
year = "2007",
month = "2",
doi = "10.1016/j.drudis.2006.12.008",
language = "English",
volume = "12",
pages = "112--124",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "3-4",

}

TY - JOUR

T1 - Targeting mammalian target of rapamycin (mTOR) for health and diseases

AU - Tsang, Chi Kwan

AU - Qi, Haiyan

AU - Liu, Leroy-Fong

AU - Zheng, X. F Steven

PY - 2007/2

Y1 - 2007/2

N2 - The macrolide rapamycin is used clinically to treat graft rejection and restenosis. Mammalian target of rapamycin (mTOR) is a central controller of cellular and organism growth that integrates nutrient and hormonal signals, and regulates diverse cellular processes. New studies have linked mTOR to several human diseases including cancer, diabetes, obesity, cardiovascular diseases and neurological disorders. Recent data have also revealed that mTOR is involved in the regulation of lifespan and in age-related diseases. These findings demonstrate the importance of growth control in the pathology of major diseases and overall human health, and underscore the therapeutic potential of the mTOR pathway.

AB - The macrolide rapamycin is used clinically to treat graft rejection and restenosis. Mammalian target of rapamycin (mTOR) is a central controller of cellular and organism growth that integrates nutrient and hormonal signals, and regulates diverse cellular processes. New studies have linked mTOR to several human diseases including cancer, diabetes, obesity, cardiovascular diseases and neurological disorders. Recent data have also revealed that mTOR is involved in the regulation of lifespan and in age-related diseases. These findings demonstrate the importance of growth control in the pathology of major diseases and overall human health, and underscore the therapeutic potential of the mTOR pathway.

UR - http://www.scopus.com/inward/record.url?scp=33846569938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846569938&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2006.12.008

DO - 10.1016/j.drudis.2006.12.008

M3 - Article

C2 - 17275731

AN - SCOPUS:33846569938

VL - 12

SP - 112

EP - 124

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 3-4

ER -